Michael Li

Dr. Michael Li, MD, MPH, is an Assistant Professor at the University of California, San Francisco (UCSF) School of Medicine, specializing in Transplant Hepatology and Gastroenterology. He provides clinical care for patients with cirrhosis, autoimmune liver diseases, and liver cancer while conducting clinical and translational research into immune-mediated liver pathologies.

• Education: MD from Icahn School of Medicine at Mount Sinai (2015), MPH from Harvard T.H. Chan School of Public Health (2021)
• Training: Internal Medicine Residency (Mount Sinai 2018), Gastroenterology Fellowship (Brigham and Women's 2021), Transplant Hepatology Fellowship (UCSF 2022)

His research focuses on immune system interactions with liver disease, particularly primary sclerosing cholangitis and immunotherapy applications for hepatocellular carcinoma. Through clinical trials and translational research, he investigates biomarkers for immunotherapy response and toxicity, proteome-wide autoantibody discovery, and innovative treatment paradigms.

Key research trends include immunotherapy optimization for liver cancer patients awaiting transplantation, autoimmune liver disease mechanisms, and clinical informatics applications in electronic health records. His work bridges basic science discovery with real-world clinical implementation.

• Scientific Awards: UCSF Liver Center Pilot Award (2023), AGA Pilot Research Award (2023), ACG Clinical Research Award (2021), AASLD Foundation Fellow (2021)
• Grants: ACG Junior Faculty Development Award (2023-2026), PSC Partners Young Investigator Award (2023-2025)

Clinically, Dr. Li has received 142 patient reviews with 4.9/5 average rating, highlighting his patient-centered approach, thorough explanations of complex liver issues, and timely care delivery. His practice locations include UCSF's Liver Disease and Liver Transplant clinic at 400 Parnassus Ave, San Francisco.